𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cancer risks in women with 2 breast or ovarian cancers: Clues to genetic cancer susceptibility

✍ Scribed by Helen S. Evans; Cathryn M. Lewis; David Robinson; C.M. Janine Bell; Henrik Møller; Shirley V. Hodgson

Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
43 KB
Volume
94
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast cancer susceptibility alleles and
Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations
✍ Margaret A. Gates; Shelley S. Tworoger; Kathryn L. Terry; Immaculata De Vivo; Da 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 79 KB

## Abstract Recent genome‐wide scans identified several novel breast cancer risk alleles, including variants of the __FGFR2__, __MAP3K1__ and __LSP1__ genes, and a study of associations between these alleles and characteristics of breast cancer patients reported a borderline significant correlation

Common genetic variants in pre-microRNAs
Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women
✍ Zhibin Hu; Jie Liang; Zhanwei Wang; Tian Tian; Xiaoyi Zhou; Jiaping Chen; Ruifen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

Small, noncoding RNA molecules, called microRNAs (miRNAs), are thought to function as either tumor suppressors or oncogenes. Common singlenucleotide polymorphisms (SNPs) in miRNAs may change their property through altering miRNA expression and/or maturation, and thus they may have an effect on thous

BRCA1 and BRCA2 mutations in women with
BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic
✍ Lenka Foretova; Eva Machackova; Marie Navratilova; Hana Pavlu; Marcela Hruba; Mi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Germline mutations in BRCA1 and BRCA2 account for majority of hereditary breast and ovarian cancer. The complete coding sequence analysis of both genes was carried out in 197 breast/ovarian cancer patients from high-risk families and 53 patients with sporadic breast/ovarian cancer. In summary, 59 mu

A recurrent CHEK2 p.H371Y mutation is as
A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women
✍ Yin Liu; Ji Liao; Ye Xu; Weiqiu Chen; Dongyun Liu; Tao Ouyang; Jinfeng Li; Tianf 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

The association between the CHEK2 and breast cancer risk in Chinese women is unknown. Here, we screened the full CHEK2 coding sequence in 118 Chinese familial breast cancer cases who are negative for mutations in BRCA1 and BRCA2, one recurrent mutation, CHEK2 c.1111C4T (p.H371Y), was identified in f